Introduction
Bone marrow transplantation from an HLA-matched sibling has been demonstrated to be a potentially curative therapy for a variety of diseases, mainly acute leukaemia, chronic myeloid leukaemia (CML) and other haematologic malignancies (Madrigal et al., 1997; Petersdorf et al., 1998; Mickelson et al., 2000) . However, given typical family size in North America and Europe, only approximately 30% of the patients to be considered for this therapy will have a HLA genotypically identical sibling. For this reason haematopoietic stem cells from HLA-matched unrelated donors are increasingly used for transplantation (Madrigal et al., 1997) . The major problem in bone marrow transplantation is the development of graftvs.-host disease (GVHD), whereby donor T lymphocytes recognize allo-HLA determinants in the recipient's tissue, leading to its destruction. For this reason, HLA matching of potential donor and recipient is essential in order to improve the outcome of bone marrow transplantation. However, the requirements with regard to HLA compatibility and the relative importance of matching for individual HLA alleles in bone marrow transplantation have not yet been established (Sasazuki et al., 1998) . In a recent study, mismatches for HLA-A and -C alleles, as determined by DNA-based typing, were found to be strong risk factors for the development of grade III or IV acute GVHD (Sasazuki et al., 1998) . In contrast, Petersdorf et al. (1998) found that mismatching for a single class I or class II allele had no significant effect on survival. However, in that study mortality was increased by mismatching for more than one class I allele and by simultaneous mismatching for class I and II alleles.
Recent advances in DNA-based typing have led to the detection of a continuously growing number of HLA class I alleles, mainly HLA-A and HLA-B (Marsh et al., 2001) . The extensive polymorphism of HLA class I molecules results from natural selection, presumably as a consequence of the advantage of T-cell responses against the diverse pathogens to which human populations are exposed. The polymorphism has evolved on the one hand by the gradual accumulation of point mutations and on the other hand by gene conversion events or recombination (Bjorkman & Parham, 1990; Parham et al., 1995) . Yet, HLA polymorphism is a major barrier for bone marrow and solid organ transplantation. For this reason, HLA matching in transplantation of haematopoietic stem cells from unrelated donors has become increasingly complicated. On account of the high HLA polymorphism, a large donor pool is necessary to increase the chances of finding an HLA-matched unrelated donor. In 1999, 6 196 341 potential bone marrow donors and cord blood units were registered worldwide, of whom 1 603 644 were HLA-A, -B and -DR split typed, representing 414 765 different phenotypes (http://www.bmdw.org). Although this number may be sufficient to provide donors for the majority of patients bearing the most common HLA antigens, it may be impossible to find an HLAcompatible donor for carriers of rare antigens. When there is no genotypically identical sibling and there are several alternative potential donors that all have a mismatch at a relevant HLA locus, no ranking system exists that indicates different levels of allogenicity. To date, the impact of HLA mismatches on allogeneic T-cell activation has not been evaluated systematically because of the large number of [n(n − 1)]/2 possible mismatches when there are n alleles to be compared with each other. The same limitation applies to clinical studies, which would have to include huge numbers of patients in order to cover all allelic mismatch combinations. Even in vitro studies will not solve this problem since they cannot cover the possible number of mismatched allele combinations, especially if a perfect allelic match at the other genes is desired. In order to find a theoretical approach to this problem and not to leave mismatching to chance, we propose a scoring system that is based on structural data of HLA class I molecules, and on data on naturally occurring frequencies of amino acid exchanges. This system considers not only the number of different amino acid residues but also their relevance with regard to antigen presentation, and the influence of their different chemical and physical properties. For demonstration, we employ our rating system for the comparison of the HLA-A*23 and A*24 groups, both of which allelic products are subdivisions of the serological HLA-A9 family, which is frequent in Caucasian (11.2%), African-American (13.2%), Asian-American (22.5%), Latin-American (16.2%) and Native-American (14.7%) populations (Mori et al., 1997) .
Materials and methods
In the alleles A*2301-A*2303 and A*2402-A*2423, all positions assigned to the α1 and α2 domains (Bjorkman et al., 1987a (Bjorkman et al., ,b, 1990 were examined for sequence differences by comparing all alleles to each other. The null alleles A*2409 and A*2411 N were excluded from the study. The allele A*2419 was also not considered, as the sequence has not yet been released. From crystallographic data on the structure of HLA class I molecules it was noted whether positions with polymorphism within the HLA-A9 family were likely to be important for peptide binding (Saper et al., 1991) or for recognition by the T-cell receptor (TCR) (Garboczi et al., 1996) .
The possible influence of amino acid substitutions on functional properties of HLA-A molecules was rated using the distance matrix by Risler et al. (1988) based on amino acid substitutions in structurally related proteins. The basic idea of Risler's score was that two distinct amino acids are less dissimilar the more often they substitute each other in different proteins. Frequent substitutions represent high functional similarity, and rare substitutions represent low functional similarity. Accordingly, the less often members of a pair of amino acids substitute each other, thus representing functional dissimilarity, the higher is the score obtained, with a maximum value of 100. For rating structure differences within the HLA-A9 family a new weighted score ('dissimilarity index') was established, which considers both position and quality of substitution: to each amino acid disparity the value of Risler's distance matrix divided by 100 was assigned. When the disparity is located at a position that is important for peptide binding and / or recognition by the TCR, the value 1 was added in order to obtain a weighted score for this position. Residues that contribute to both functional properties were rated as if they possessed only one function, because there are no data indicating that their role is of major importance compared to positions that are important for only one function. The described algorithm results in higher scores even for low disparity at functionally relevant positions compared to any disparity at positions that are probably of functionally minor importance. In order to obtain the dissimilarity index, the scores representing the single amino acid substitutions were added up.
Results
Polymorphic positions in the α1 and α2 domains and assignment to the peptide binding region and the region important for recognition by the TCR are shown in Table 1 . Table 2 (lower left section) shows the number of amino acid disparities within the HLA-A9 family. The extensive polymorphism within this group is revealed, with up to 17 residue disparities, 11 of them located at positions important for peptide binding or TCR recognition (A*2404 vs. A*2416). All expressed A9 variants differ from each other by at least one residue disparity in the α1 or α2 domain. Overall dissimilarity indices of amino acid comparisons are shown in Table 2 (upper right section).
The use of the dissimilarity index is illustrated in the following. For example, the alleles HLA-A*2402 and A*2405 differ by one residue (K vs. Q) at position 144, which is important neither for peptide binding nor for recognition by the TCR (Tables 1 and 2 , lower left section). Lysine (K) and glutamine (Q) have been previously reported to substitute one another comparatively often, which has resulted in the score of 13 from Risler's matrix. In order to obtain the dissimilarity index, Risler's score is divided by 100.
In contrast, the alleles A*2402 and A*2406 differ by one residue (Q vs. W) located at position 158, which is likely to be important for recognition by the TCR. Glutamine and tryptophane (W) have been previously reported to substitute one another comparatively rarely, which has resulted in the score of 80 from Risler's matrix. In this case, the dissimilarity index is 1.80, as Risler's score is first divided by 100, and then 1 is added.
Besides the extensive polymorphism, Table 2 (upper right section) also demonstrates that most A*24 alleles show a greater difference to at least one other A*24 variant than to A*2301. Surprisingly, matching of A*2413 with A*2301 give a dissimilarity index of 1.77, which is lower than the indices yielded for comparisons between 
Numbers in the first line refer to the position within the HLA-A molecule. Amino acid residues are represented by the one-letter code. Bold text represents those residues that differ from the residue that is present at this position in the majority of HLA-A9 variants. + represents involvement of residues in TCR or peptide binding; -represents no involvement. 
Discussion
HLA class I molecules are heterodimeric cell surface glycoproteins that present antigenic peptides to CD8+ T cells and thus are crucial for the specificity of cellular immunity. The extracellular portion of the heavy chain has been divided into three domains called α1, α2 and α3 that are followed by a membrane-spanning region and a cytoplasmic tail. The α3 domain shows little within-group polymorphism and is important for interaction with the CD8 glycoprotein of the T cell. The peptide-binding site is formed by amino acid residues that belong to the α1 and α2 domains (Bjorkman et al., 1987a,b; Saper et al., 1991) . Residues on the α-helices with side-chains pointing 'up' from the surface are important for direct recognition by the TCR (Garboczi et al., 1996) . Residues located on the α-helices with side-chains in an intermediate position could interact with either peptides or TCR (Bjorkman et al., 1987a,b; Saper et al., 1991; Garboczi et al., 1996) . Differences in the amino acid alignments of HLA class I molecules are predominantly found in the α1 and α2 domains, many of them in residues that line the sides and the bottom of the peptide-binding groove. This finding correlates with the observed specificity in peptide binding to individual HLA class I molecules (Bjorkman et al., 1987a (Bjorkman et al., ,b, 1990 Garrett et al., 1989; Saper et al., 1991) . Crystallographic data on HLA-A2 and HLA-A68 revealed that the amino acid residues involved in peptide binding can be assigned to six specificity pockets (Garrett et al., 1989; Saper et al., 1991) , of which pockets B and F, which bind P2 and P9 of the presented peptide, have been demonstrated to be crucial for determination of the allelic peptide motif (Falk et al., 1991; Parker et al., 1992; Carreno et al., 1993; Rammensee et al., 1993) .
Variations in the peptides bound by related HLA class I molecules have been reported (Rötzschke et al., 1992) . However, peptide-binding specificities of closely related HLA class I molecules can be strikingly similar (Sidney et al., 1996) . Corresponding to crystallographic data (Bjorkman et al., 1987a (Bjorkman et al., ,b, 1990 Garrett et al., 1989; Saper et al., 1991) these findings indicate that, rather than genetic relatedness itself, the position and type of amino acid exchanges between HLA molecules are pivotal for the peptides preferentially bound.
Allogeneic recognition by CD8+ T cells is thought to be brought about by different mechanisms. The high determinant density hypothesis (Bevan, 1984) proposes that the receptor of the alloreactive T cell is specific for the foreign HLA molecule itself, irrespective of the peptides bound (if present at all), which may be true in some cases, as experimental data suggest (Smith et al., 1997) . However, most studies suggest the involvement of the presented peptide. Experimental data suggest that alloreactive T-cell clones recognize unique peptides in the context of allogeneic HLA class I molecule (Heath et al., 1991) , conformational changes of presented peptides (Herman et al., 1999) , or peptide-induced conformational changes of the HLA molecule (Bluestone et al., 1993) , whereby subtle changes in the peptide environment may impact alloreactivity (Rudolph et al., 2001 ).
Yet, only in the most extreme cases might it be possible to show that either peptide or MHC plays a more dominant role in a TCR-allo-MHC interaction (Kranz, 2000) .
In order to approach the clinical problem of finding the best-fitting donor in unrelated bone marrow transplantation, we propose a scoring system based on knowledge of allogeneic recognition and the structure of HLA class I molecules. This dissimilarity index considers both position and quality of residue disparities between compared alleles. The possible influence of the exchange of amino acid residues is rated on the basis of Risler's distance matrix, supposing that the more similar two amino acids are rated to be, the smaller is the impact on peptide binding and / or recognition by the TCR. This algorithm results in higher dissimilarity indices even for low disparity at functionally relevant positions compared to any disparity at positions that are probably of functionally minor importance. Using this method, remarkable differences between HLA-A9 subtypes were revealed, as shown in Table 2 (upper right section).
When possible, the donor carrying the allele with the lowest dissimilarity index may be preferred. As stated above, comparison of the alleles A*2402 and A*2405 yields the dissimilarity index 0.13, whereas comparison of A*2402 and A*2406 gives 1.80. Accordingly, when there is a patient carrying A*2402, a potential bone marrow donor carrying HLA-A*2405 who differs from the patient only by this single allele may be preferred to a HLA-A*2406-carrying donor. Although both A*2405 and A*2406 differ from A*2402 by one amino acid each, the dissimilarity index enables a similarity analysis that is superior to simply counting the number of differences. Table 2 (upper right section) also reveals that most A*24 alleles show a greater difference to at least one other A*24 variant than to A*2301. Particularly, this observation may be of clinical significance in the mismatching of A*2413 with A*2301, which gives a dissimilarity index of 1.77, which is lower than the indices obtained for comparisons between A*2413 and most other A*24 alleles. This difference between functional similarity and serological relatedness may be explained by an overriding influence of distinct epitopes of the HLA class I molecule on serological recognition that only in part reflects the genetic (Hildebrand et al., 1992) or functional relationship of alleles. Yet, it has to be considered that names of alleles do not always reflect their relationship since the serological assignment of some alleles is unlikely to be known with certainty.
The dissimilarity index provides a simple tool for comparing similarity between different allelic combinations. However, some limitations have to be considered. In order to distinguish between residues of major (peptide-binding site and / or contact with the TCR) or minor (remaining residues of the α1 and α2 domains) importance, crystallographic data obtained from HLA-A2 (Saper et al., 1991; Garboczi et al., 1996) were used, as there are no data on the threedimensional structure of A9 molecules. Although previous data suggest a great structural similarity between all HLA-A molecules (Bjorkman et al., 1987a,b; Saper et al., 1991; Garboczi et al., 1996) , there may be some minor differences from A9 which may not be reflected correctly by the dissimilarity index. Furthermore, in order not to complicate the index, peptide-binding regions and regions that have contact with the TCR were regarded as equally important. This procedure also avoids the problem of assessment of positions that can be allocated both to the peptide-binding regions and the regions important for contact with the TCR. The dissimilarity index does not weight the assignment of residues to pockets B and F as the binding site is a continuous surface, and designating the beginning and end of such pockets is somewhat arbitrary (D. C. Wiley, Department of Molecular and Cellular Biology, Harvard University, Cambridge, MAUSA, personal communication). This suggestion is supported by the finding that single residue exchanges at positions that cannot be assigned to pockets B or F may also lead to strong alloreactivity (Herman et al., 1999) .
The Bw4 / Bw6 epitope has been reported to strongly influence binding of antigenic peptides (Hill et al., 1992) . Accordingly, the absence of the Bw4 epitope in A*2404 (Kashiwase et al., 1995) , which results in the exchange of the residues 76, 79, and 80 -83 ( Table 1) , is likely to enhance allogenicity in the case of a mismatch with other A*24 alleles. In order not to complicate the dissimilarity index proposed here, the influence of residues on allogenicity was rated regardless of possible allocation to the Bw4 / Bw6 epitope. Since the exchange of this epitope always comprises several residues, some of them involved in peptide binding (Saper et al., 1991) , comparisons between alleles that differ by Bw4/Bw6 will always yield high dissimilarity indices, as shown here for A*2404 (Table 2 , upper right section).
In the algorithm described here, different residues at functionally relevant positions always yield higher scores, even for low disparity, compared to any disparity at positions that are probably of functionally minor importance. In some cases, the relation between functionally important and less important regions of the HLA molecule thus may be not reflected linearly. For this reason, the dissimilarity index may over-or underestimate exchanges in regions important for peptide binding or T-cell attachment compared to changes in other regions of the HLA molecule. Risler's score, which has been used in order to rate the impact of amino acid exchanges on peptide binding, is based on frequencies of naturally occurring amino acid substitutions in structurally related proteins. Similarities between distinct amino acids in this score often, but not always, correlate with chemical or physical properties (Grantham, 1974; Risler et al., 1988; Stanfel, 1996) . We preferred Risler's score to other matrices as it reflects functional similarity or disparity in the context of complete proteins, whereas other scores only represent classification on the basis of physical and chemical properties of the single components (Grantham, 1974; Stanfel, 1996) .
Evidence that sequence similarity matching may be a useful strategy for bone marrow transplantation has come from previous studies on renal allograft transplantation. Takemoto & Terasaki (1996) proposed a matching procedure for kidney transplantation based on the three polymorphic positions of HLA molecules which were shown to be oriented upwards to the TCR (Bjorkman et al., 1987a,b) . This procedure yielded very similar results compared to conventional HLA matching. The probable correlation between mismatch of functionally important amino acid residues of HLA class II molecules and outcome of renal transplantation was also analysed in the study by Sada et al. (1997) . They found that rejection occurrence correlated with incompatible DRB1 amino acid residues on the β-pleated sheet.
In addition to our scoring system, a sophisticated mathematical model for comparing HLA alleles has been proposed by Cano et al. (1998) , in which data on peptide binding by different HLA class I alleles were used to calculate an empirical similarity matrix between HLA alleles. This model may be a very interesting approach for sequence similarity matching in bone marrow transplantation. However, it is based only on peptide binding, and does not consider recognition of superficial residues of the HLA molecule by the TCR which is also of importance for immunotolerance in bone marrow transplantation. Nevertheless, this proposed model deserves further attention and correlation to clinical data may be promising.
By using the dissimilarity index proposed here, remarkable differences between the HLA-A9 subtypes were revealed, which are superior to a simple sequence comparison, as both the function of the residues and the quality of the exchange are considered. Within the limitations discussed above, new scoring matrices can also easily be established for other HLA genes and allelic groups. For HLA-DR and -DQ, a crystallographic analysis of the TCR-peptide-MHC complex still needs to be performed, so that transfer of the algorithm described above to HLA class II will be somewhat limited.
Because of the large number of possible mismatches, only a small fraction can be covered by systematic in vitro experiments and by clinical studies. Furthermore, in addition to the HLA match the outcome of unrelated-donor bone marrow transplantation is dependent on other factors such as cell dose, age, gender, cytomegalovirus status of the recipient, and ethnic group (Davies et al., 2000) . Accordingly, the HLA match is only one player in the donor selection algorithm, and the scoring system proposed here may help to weight the immunogenetic variable in the selection procedure. Studies focusing on the systematic analysis of a reduced number of mismatches may be helpful in order to further improve the theoretical model proposed here. However, as long as such studies are not available, present knowledge of the structure and function of HLA molecules, as in part reflected by the dissimilarity index, may be utilized in order to prevent HLA mismatching being a matter of chance.
